NCHR Testimony on the Opioid Oliceridine

October 11, 2018. There are many unanswered questions about what dosages work and are safe for which patients under which conditions. We all know that is an epidemic of opioid use, so these questions must be answered before a decision is made about whether or not to approve oliceridine.

Read More »

NCHR Testimony on WEB Aneurysm Embolization System

September 27, 2018. There are important aspects of the clinical trial that make it difficult to determine if the WEB device is effective and safe for the indicated population. If the FDA does not demand better research, patients and their physicians may never know the answers to those questions.

Read More »
Page 4 of 42« First...23456...102030...Last »